FIELD: medicine.
SUBSTANCE: invention refers to medicine, oncology, and can be used for treating rectal cancer. That is ensured by an intramuscular introduction of ingaron 500000-1000000 IU ml for 5-10 days to a patient once a day. It is followed with an irradiation procedure in a dynamic dose fractionation mode. The first three coarse irradiation fractions are combined with carboplatin 300-450 mg/m2. Daily during the whole irradiation course, xeloda 500-1500 mg/m2 is introduced as a radio sensitiser.
EFFECT: method allows achieving the manifested regress of a primary tumour, increasing a life span ensured by lower frequency of remote metastases and recurrences, well tolerable by the patients and promotes improving life quality in the inoperable cases.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING ADENOGENOUS LOCALLY ADVANCED CANCER OF LOWER AMPULLARY PART OF RECTUM | 2013 |
|
RU2547999C1 |
METHOD FOR TREATING LOW-LYING TUMORS OF RECTUM AND ANAL CANAL | 2017 |
|
RU2666694C1 |
METHOD OF TREATMENT OF UNRESECTABLE PANCREATICODUODENAL CANCER | 2007 |
|
RU2341308C1 |
METHOD FOR CHEMORADIATION OF RECTUM AND ANAL CANAL TUMORS | 2016 |
|
RU2629599C1 |
METHOD OF TREATING RECTAL CANCER | 2015 |
|
RU2586042C1 |
METHOD OF TREATMENT OF LUMINAL SUBTYPE OF BREAST CANCER N1 IN POSTMENOPAUSAL PERIOD | 2016 |
|
RU2624370C1 |
METHOD OF COMBINATION TREATMENT OF LOCALLY ADVANCED RECTAL CANCER | 2010 |
|
RU2447914C1 |
METHOD OF TREATING RECTAL CANCER | 2009 |
|
RU2398608C1 |
METHOD FOR SELECTING THERAPEUTIC APPROACH TO LOCALLY ADVANCED PROSTATE CANCER | 2013 |
|
RU2524309C1 |
METHOD OF TREATING RECTAL CANCER | 2018 |
|
RU2691345C1 |
Authors
Dates
2011-07-20—Published
2010-02-04—Filed